↓ Skip to main content

Treatment of melasma in Caucasian patients using a novel 694-nm Q-switched ruby fractional laser

Overview of attention for article published in European Journal of Medical Research, November 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

facebook
1 Facebook page
googleplus
1 Google+ user

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
34 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Treatment of melasma in Caucasian patients using a novel 694-nm Q-switched ruby fractional laser
Published in
European Journal of Medical Research, November 2013
DOI 10.1186/2047-783x-18-43
Pubmed ID
Authors

Said Hilton, Heike Heise, Bettina Alexandra Buhren, Holger Schrumpf, Edwin Bölke, Peter Arne Gerber

Abstract

Melasma is a common hypermelanosis of the face. The use of a classical Q-switched ruby laser (QSRL) to treat melasma is discussed controversially and is associated with frequent adverse effects, such as hyper- or hypopigmentation. Recently a fractional-mode (FRx) QSRL was developed to minimize the adverse effects of classical QSRL. The objective of this research was to evaluate the efficacy and safety of a novel FRx-QSRL in the treatment of melasma in Caucasian patients.

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Slovenia 1 3%
Unknown 33 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 21%
Other 5 15%
Student > Bachelor 3 9%
Lecturer 3 9%
Researcher 3 9%
Other 9 26%
Unknown 4 12%
Readers by discipline Count As %
Medicine and Dentistry 18 53%
Nursing and Health Professions 4 12%
Unspecified 1 3%
Biochemistry, Genetics and Molecular Biology 1 3%
Business, Management and Accounting 1 3%
Other 2 6%
Unknown 7 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 January 2014.
All research outputs
#7,499,760
of 12,440,396 outputs
Outputs from European Journal of Medical Research
#110
of 234 outputs
Outputs of similar age
#111,020
of 227,614 outputs
Outputs of similar age from European Journal of Medical Research
#7
of 17 outputs
Altmetric has tracked 12,440,396 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 234 research outputs from this source. They receive a mean Attention Score of 4.8. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 227,614 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.